pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 368 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
promethazine
Promethazine Hydrochloride (promethazine [INN])
Allergic Conjunctivitis
Nostrum Laboratories LLC
0 catalysts
Marketed
ranibizumab
Lucentis (ranibizumab)
Choroidal Neovascularization
Genentech Inc
0 catalysts
Marketed
revakinagene taroretcel
Encelto (revakinagene taroretcel-iwey)
Idiopathic Juxtafoveolar Retinal Telangiectasis (IJRT)
Neurotech Pharmaceuticals Inc
0 catalysts
← prev
page 12 of 13
next →
131
Pain89
Neurology1
Phase 3
ripasudil hydrochloride
Fuchs Endothelial Corneal Dystrophy (FECD)
Rho-associated protein kinase
Kowa Co Ltd
0 catalysts
Phase 2
risuteganib
Luminate (risuteganib)
Dry (Atrophic) Macular Degeneration
Allegro Ophthalmics LLC
0 catalysts
Phase 2
rivasterat
rivasterat [INN]
Diabetic Macular Edema
Thea Open Innovation SASU
0 catalysts
Phase 3
satralizumab
Enspryng (satralizumab-mwge)
Demyelinating Diseases
IL6Ralpha/GP130
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 3
selenium sulfide
Selenium Sulfide (selenium sulfide [USP])
Meibomian Blepharitis
Azura Ophthalmics Pty Ltd
0 catalysts
Phase 2
sepetaprost
sepetaprost [INN]
Ocular Hypertension
Santen Pharmaceutical Co Ltd
0 catalysts
Marketed
short ragweed pollen (Ambrosia artemisiifolia) allergen extract ODT
Ragwitek
Ragweed Pollen Allergy
ALK-Abello Inc
0 catalysts
Phase 3
sonpiretigene isteparvovec
Retinitis Pigmentosa (Retinitis)
Nanoscope Therapeutics Inc
0 catalysts
Phase 2
sozinibercept
Diabetic Macular Edema
$CKDXFOpthea Ltd
0 catalysts
Marketed
standardized grass pollen [timothy (Phleum pratense)] allergen extract
Grastek
Allergic Rhinitis
ALK-Abello Inc
0 catalysts
Marketed
standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract
Odactra
Allergic Rhino-Conjunctivitis
ALK-Abello Inc
0 catalysts
Marketed
sulfadiazine
Sulfadiazine (sulfadiazine)
Otitis Media
Epic Pharma LLC
0 catalysts
Marketed
sulfisoxazole
Sulfisoxazole (sulfisoxazole)
Bacterial (Pyogenic) Meningitis
Roxane Laboratories Inc
0 catalysts
Phase 3
surabgene lomparvovec
Wet (Neovascular / Exudative) Macular Degeneration
$ABBVAbbVie Inc.
0 catalysts
Phase 3
tarcocimab tedromer
Retinal Vein Occlusion
$KODKodiak Sciences Inc.
0 catalysts
Phase 1
tasronetide
tasronetide [INN]
Optic Neuropathy
Find Therapeutics Inc
0 catalysts
Phase 3
tavilermide
Keratoconjunctivitis Sicca (Dry Eye)
Mimetogen Pharmaceuticals Inc
0 catalysts
Marketed
tetracycline hydrochloride
Tetracycline Hydrochloride (tetracycline hydrochloride)
Actinomycosis
Amneal Pharmaceuticals of New York LLC
0 catalysts
Phase 3
timbetasin acetate
Neurotrophic Keratitis
ReGenTree LLC
0 catalysts
Phase 2
timolol
Ocular Hypertension
Beta-1 adrenergic receptorBeta-2 adrenergic receptor
Betaliq Inc
0 catalysts
Phase 3
tinlarebant
Geographic Atrophy
$BLTEBELITE BIO, INC
0 catalysts
Phase 2
tivozanib
Wet (Neovascular / Exudative) Macular Degeneration
Platelet-derived growth factor receptor betaVascular endothelial growth factor receptor
Kyowa Kirin Co Ltd
0 catalysts
Marketed
tobramycin
Tobramycin Sulfate (tobramycin)
Bacteremia
Hikma Pharmaceuticals USA Inc
0 catalysts
Phase 2
tonabersat
Xiflam (tonabersat [INN])
Diabetic Nephropathy
Inflammx Therapeutics Inc
0 catalysts
Preclinical
triamcinolone acetonide SR
triamcinolone acetonide [INN]
Diabetic Macular Edema
$GKOSGLAUKOS Corp
0 catalysts
Marketed
trifluridine
Trifluridine (trifluridine)
Herpetic Keratitis
Sandoz Inc
0 catalysts
Marketed
tropicamide
Mydriacyl (tropicamide)
Cycloplegia
Alcon Laboratories Inc
0 catalysts